equities

Sanofi Gets FDA Approval for Highest Capacity Long-Acting Insulin Pen

Sanofi (Euronext: SAN; NYSE: SNY) announced today that it received FDA approval for its Toujeo Max SoloStar insulin pen, the highest capacity long-acting insulin pen that will be available on the ...
The Pharma Letter

Sandoz confirms EC approval of Ondibta biosimilar

Switzerland-based Sandoz, a global leader in affordable medicines, today confirmed that the European Commission has granted ...
Business Wire

Global Insulin Pen Market Report 2023 to 2028, Fueled by Growing Diabetic Population - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Insulin Pen Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market is projected to achieve a significant ...
Pharmabiz

Sanofi inaugurates Lantus SoloSTAR pen assembly plant in its Beijing facility

Sanofi has inaugurated a new assembling and packaging line to produce its flagship pre-filled insulin injection pen Lantus SoloSTAR at its Beijing plant located at the Beijing Economic-Technological ...
Healio

Q&A: What to know about ultra-long-acting insulins

Please provide your email address to receive an email when new articles are posted on . O’Brien: An initial response is to consider the individual’s insurance formulary. However, when an insurance ...
FiercePharma

Sanofi, Roche team up to drive adoption of smart insulin pen

Sanofi and Roche have joined forces in France, teaming up to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific program for physicians and ...